Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Fleischer

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 13, 2026
Molecular profiling of chemotherapy-resistant breast cancer reveals DNA methylation remodeling associated with the acquisition of paclitaxel resistanceLenka Trnkova, Monika Burikova, Andrea Soltysova, et al.
Epigenetics|January 23, 2019
EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLCRuyang Zhang, Linjing Lai, Jieyu He, et al.
Aging|August 23, 2019
Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinomaXuesi Dong, Ruyang Zhang, Jieyu He, et al.
Molecular Oncology|March 30, 2019
SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic-smoking interaction analysisRuyang Zhang, Linjing Lai, Xuesi Dong, et al.
Aging|June 9, 2020
Epigenome-wide gene-age interaction analysis reveals reversed effects of <i>PRODH</i> DNA methylation on survival between young and elderly early-stage NSCLC patientsChao Chen, Yongyue Wei, Liangmin Wei, et al.
Chest|March 2, 2020
Independent Validation of Early-Stage Non-Small Cell Lung Cancer Prognostic Scores Incorporating Epigenetic and Transcriptional Biomarkers With Gene-Gene Interactions and Main EffectsRuyang Zhang, Chao Chen, Xuesi Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2017
The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast CancerLaxmi Silwal-Pandit, Silje Nord, Hedda von der Lippe Gythfeldt, et al.
Nature Communications|April 17, 2019
Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylationArie B Brinkman, Serena Nik-Zainal, Femke Simmer, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 13, 2026
Molecular profiling of chemotherapy-resistant breast cancer reveals DNA methylation remodeling associated with the acquisition of paclitaxel resistanceLenka Trnkova, Monika Burikova, Andrea Soltysova, et al.
Epigenetics|January 23, 2019
EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLCRuyang Zhang, Linjing Lai, Jieyu He, et al.
Aging|August 23, 2019
Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinomaXuesi Dong, Ruyang Zhang, Jieyu He, et al.
Molecular Oncology|March 30, 2019
SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic-smoking interaction analysisRuyang Zhang, Linjing Lai, Xuesi Dong, et al.
Aging|June 9, 2020
Epigenome-wide gene-age interaction analysis reveals reversed effects of <i>PRODH</i> DNA methylation on survival between young and elderly early-stage NSCLC patientsChao Chen, Yongyue Wei, Liangmin Wei, et al.
Chest|March 2, 2020
Independent Validation of Early-Stage Non-Small Cell Lung Cancer Prognostic Scores Incorporating Epigenetic and Transcriptional Biomarkers With Gene-Gene Interactions and Main EffectsRuyang Zhang, Chao Chen, Xuesi Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2017
The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast CancerLaxmi Silwal-Pandit, Silje Nord, Hedda von der Lippe Gythfeldt, et al.
Nature Communications|April 17, 2019
Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylationArie B Brinkman, Serena Nik-Zainal, Femke Simmer, et al.
Pageof 5